| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.1 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.089 | 0.1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.1 |